Search Results
1 - 12 of 21 matches
Sort by:
Impact of SGLT2 Inhibitors on Mortality and Cardiovascular Admissions in Heart Failure With Reduced Ejection Fraction (HFrEF)
Presenter:
Jonathan Zawadzki
February 12, 2025
Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction
Presenter:
Emmanuel Otabor
February 11, 2025
Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction
Presenter:
Emmanuel Otabor
February 11, 2025
TCT 304: SGLT2 Inhibitor Empagliflozin Before Coronary Angiography: Can We Reduce Patient Stress?
Presenter:
Katica Cvitkusic Lukenda
October 27, 2024
TCT 185: Clinical Outcomes of SGLT2 Inhibitors Among Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair
Presenter:
Samarthkumar Thakkar
October 27, 2024
Expanding Your Lane and Not Your Waist: Cardiologists and GLP1-RA/SGLT2i
Presenter:
Eldrin Lewis
October 26, 2023
SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits
Presenter:
Milton Packer
March 20, 2023
The Impact of SGLT2 Inhibitors Across the Spectrum of Heart Failure
Presenter:
Scott Solomon
March 20, 2023
Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond
Presenter:
Marc Bonaca
September 17, 2022
EMPULSE: The Use of SGLT2 Inhibitors in Acute Decompensated Heart Failure
Presenter:
Piotr Ponikowski
February 1, 2022